← FDA Drug Approvals (Drugs@FDA)

ATOVAQUONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2017-04-28

Drug application

FDA Application #
ANDA207833
Application type
Abbreviated New Drug Application (Generic)
Brand name
ATOVAQUONE
Generic name
ATOVAQUONE
Active ingredients
ATOVAQUONE
Dosage form
SUSPENSION
Route
ORAL
Marketing status
Prescription
Sponsor
CHARTWELL RX
Manufacturer
Chartwell Governmental & Specialty RX, LLC.
First approval
2017-04-28

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown